Abstract

Diet-induced hyperhomocysteinemia produces endothelial and cardiac dysfunction and promotes thrombosis through a mechanism proposed to involve oxidative stress. Inducible nitric oxide synthase (iNOS) is upregulated in hyperhomocysteinemia and can generate superoxide. We therefore tested the hypothesis that iNOS mediates the adverse oxidative, vascular, thrombotic, and cardiac effects of hyperhomocysteinemia. Mice deficient in iNOS (Nos2−/−) and their wild-type (Nos2+/+) littermates were fed a high methionine/low folate (HM/LF) diet to induce mild hyperhomocysteinemia, with a 2-fold increase in plasma total homocysteine (P<0.001 vs. control diet). Hyperhomocysteinemic Nos2+/+ mice exhibited endothelial dysfunction in cerebral arterioles, with impaired dilatation to acetylcholine but not nitroprusside, and enhanced susceptibility to carotid artery thrombosis, with shortened times to occlusion following photochemical injury (P<0.05 vs. control diet). Nos2−/− mice had decreased rather than increased dilatation responses to acetylcholine (P<0.05 vs. Nos2+/+ mice). Nos2−/− mice fed control diet also exhibited shortened times to thrombotic occlusion (P<0.05 vs. Nos2+/+ mice), and iNOS deficiency failed to protect from endothelial dysfunction or accelerated thrombosis in mice with hyperhomocysteinemia. Deficiency of iNOS did not alter myocardial infarct size in mice fed the control diet but significantly increased infarct size and cardiac superoxide production in mice fed the HM/LF diet (P<0.05 vs. Nos2+/+ mice). These findings suggest that endogenous iNOS protects from, rather than exacerbates, endothelial dysfunction, thrombosis, and hyperhomocysteinemia-associated myocardial ischemia-reperfusion injury. In the setting of mild hyperhomocysteinemia, iNOS functions to blunt cardiac oxidative stress rather than functioning as a source of superoxide.

Highlights

  • Hyperhomocysteinemia is an established risk factor for cardiovascular disease and stroke [1,2]

  • In certain pathological conditions such as diabetes and atherosclerosis, isoform of NOS (iNOS) has been proposed to be a mediator of increased oxidative stress and impaired vascular function

  • Because hyperhomocysteinemia causes upregulation of vascular iNOS expression and increases vascular oxidative stress [22,34], we hypothesized that genetic deficiency of iNOS might protect against hyperhomocysteinemia-induced vascular dysfunction and thrombosis

Read more

Summary

Introduction

Hyperhomocysteinemia is an established risk factor for cardiovascular disease and stroke [1,2]. Hyperhomocysteinemia has been proposed to exert its adverse effects in the vasculature in part by generating vascular oxidative stress that diminishes the bioavailability of endothelial-derived nitric oxide (NO) [3]. Studies in diabetic mice revealed that deficiency of iNOS or reversal of iNOS uncoupling restores endothelium-dependent relaxation [16,17] and tolerance to myocardial ischemia/reperfusion (I/R) injury [18,19]. These studies suggest a role for iNOS in the pathophysiology of multiple types of cardiovascular disease

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call